Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “INTEGRATED DNA TECHNOLOGIES, INC.”

15 pharma patents match "INTEGRATED DNA TECHNOLOGIES, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 15
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 15 pharmaceutical patents matching "INTEGRATED DNA TECHNOLOGIES, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

15 results for “INTEGRATED DNA TECHNOLOGIES, INC.” · 30,257 patents in full index Clear search

  1. US 10653800

    Oligonucleotide-based probes for detection of bacterial nucleases

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted May 19, 2020 · Expires May 14, 2040

    granted

  2. US 10233450

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  3. US 10106792

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  4. US 9988630

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted

  5. US 9873875

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted

  6. US 9603949

    Oligonucleotide-based probes for detection of bacterial nucleases

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  7. US 9518262

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  8. US 9441227

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  9. US 9365849

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  10. US 8883996

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  11. US 8809515

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  12. US 8796444

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  13. US 8691786

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  14. US 8658356

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  15. US 8084599

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.